XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 1,665,155 $ 1,378,548
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 280,211 308,945
Amortization of operating right of use asset 15,577 14,829
Stock compensation expense 150,000 85,375
Bad debt expense 100,044 75,000
(Increase) decrease in:    
Accounts receivables (259,388) (547,809)
Long-term receivables, prepaids and other assets 6,455 216,340
Increase (decrease) in:    
Accounts payable 66,669 (116,499)
Operating lease liability (15,511) (57,164)
Accrued liabilities (284,097) (14,218)
Deferred revenue 143,785 177,423
Net cash provided by operating activities 1,868,900 1,520,770
Cash flows from investing activities:    
Sale of marketable securities 34,086 0
Net cash provided by investing activities 34,086 0
Cash flows from financing activities:    
Common Stock buyback/retirement 0 (1,322,082)
Redemption of Series B Preferred (749,995) 0
Proceeds from employee stock plan 59,852 57,743
Dividends paid (422,954) (421,248)
Payments on notes payable and capital leases (153,545) (128,834)
Net cash used in financing activities (1,266,642) (1,814,421)
Net increase (decrease) in cash and cash equivalents 636,344 (293,651)
Cash and cash equivalents at beginning of period 25,153,862 23,990,879
Cash and cash equivalents at end of period 25,790,206 23,697,228
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 312,098 221,661
Cash paid for interest 2,005 2,329
Cash paid for operating leases $ 18,686 $ 18,141
Common stock to pay accrued liabilities (in shares) 69,985 37,500
Dividends accrued on preferred stock $ 107,882 $ 146,611
Right-of-use asset $ 289,734 $ 0